![](https://www.diabetesnews.com/wp-content/uploads/2012/04/Statin-Medicines-150x150.jpg)
Allison Goldfine, M.D., Section of Clinical, Behavioral & Outcomes Research at Joslin Diabetes Center, is responding to the controversy in her editorial titled “Statins: Is It Really Time to Reassess Benefits and Risks?”
Read more
Allison Goldfine, M.D., Section of Clinical, Behavioral & Outcomes Research at Joslin Diabetes Center, is responding to the controversy in her editorial titled “Statins: Is It Really Time to Reassess Benefits and Risks?”
Read more